
Lansojoy 30 Tablet DT
Marketer
Foregen Healthcare Ltd
Salt Composition
Lansoprazole (30mg)
Overview Lansojoy 30 Tablet DT
Stomach acid production is decreased by the medication Lansoprazole 30mg (DT), indicated for gastrointestinal disorders stemming from excess acidity. These include acid reflux, peptic ulcers, and other hyperacidity-related conditions. Lansoprazole 30mg (DT) also serves as a preventative measure against stomach ulcers and hyperacidity potentially induced by long-term painkiller use. Classified as a proton pump inhibitor (PPI), it's optimally ingested one hour prior to meals, ideally in the morning. Dosage is individualized based on the patient's condition and response. Continued use as prescribed is crucial, even with rapid symptom resolution. Smaller, more frequent meals alongside avoidance of caffeine (tea, coffee), spicy, and fatty foods enhance treatment efficacy. Common, generally mild, side effects encompass nausea, headache, gas, abdominal discomfort, constipation, and diarrhea. Persistent or bothersome effects necessitate medical consultation. Extended use elevates the risk of adverse events; prolonged use (over one year), particularly at higher doses, may increase bone fracture risk. Discuss bone loss (osteoporosis) prevention strategies, such as calcium and vitamin D supplementation, with your physician. Prior to commencing treatment, disclose any severe liver impairment, HIV medication use, prior allergic reactions to similar medications, or pre-existing osteoporosis to your doctor. This also applies to pregnant or breastfeeding individuals.
Primary Ingredients of Lansojoy 30 Tablet DT
No text provided to rephrase.
Uses of Lansojoy 30 Tablet DT
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Lansojoy 30 Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve Lansojoy 30 DT Tablet in water before consumption. Administer on an empty stomach.
Common Side effects of Lansojoy 30 Tablet DT:
- Nausea
- Headache
- Flatulence
- Diarrhea
- Abdominal pain
- Constipation
How to use Lansojoy 30 Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Lansojoy 30 Tablet DT in water before consumption. Administer on an empty stomach.
How Lansojoy 30 Tablet DT works:
Lansojoy 30 DT tablets are proton pump inhibitors (PPIs) that decrease stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Lansojoy 30 DT tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Lansojoy 30 DT tablets is contraindicated during pregnancy due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician may deem the benefits outweigh the risks and prescribe the medication. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Lansojoy 30 DT tablets while breastfeeding is likely inadvisable. Preliminary human research indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving should be avoided if taking Lansojoy 30 DT tablets leads to drowsiness, blurred vision, or dizziness, as these are potential side effects.
KidneySAFE IF PRESCRIBED
Lansojoy 30 DT tablets pose no safety concerns for patients with kidney disease; no dosage modification is necessary.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Lansojoy 30 mg sustained-release tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Lansojoy 30 Tablet DT :
Should you forget to take a Lansojoy 30 DT Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lansojoy 30 Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Timoprazole Analog |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
